Skip to main content
OpenTrials
Completed

NCT Number: NCT07069634

Teach Back Method on Depression Levels in Hemodialysis Patients

Background: Depression is one of the most common psychiatric disorders among hemodialysis patients and is associated with increased morbidity and mortality. Due to the chronic nature of the disease and the burdens of treatment, patients often experience psychological distress. The Teach-Back Method is a patient education strategy that ensures comprehension and retention by having patients repeat the information in their own words, and has shown promise in managing chronic conditions.

Objective: This study aimed to evaluate the effect of individualized education using the Teach-Back Method on the depression levels of adult patients undergoing hemodialysis.

Methods: This was a two-center, randomized controlled interventional study with a pre-test-post-test design. A total of 40 patients with End-Stage Renal Disease (ESRD), aged between 18-65, who had been receiving hemodialysis for at least three months, were randomly assigned to intervention (n=20) and control (n=20) groups. The intervention group received three sessions of individualized education using the Teach-Back Method, while the control group received no intervention during the study. Depression levels were assessed using the Beck Depression Inventory (BDI) before and three months after the intervention.

Hypothesis

H1: Individual education provided using the Teach-Back Method reduces the level of depression in adult ESRD patients receiving hemodialysis treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Health Sciences Faculty of Nursing

Istanbul, 34668, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Those who have been diagnosed with end-stage renal failure and have received hemodialysis treatment 3 times a week for 4 hours for at least 3 months, have no communication problems and are between the ages of 18-65

Exclusion criteria

  • Patients who did not attend any of the educational sessions

Treatment and study plan

Individual training using the Teach Back Method

Other

Day 1 (Monday): Patients are introduced to the study; consent forms are signed, and initial forms are completed. An educational booklet is provided and explained. General information about hemodialysis and treatment is delivered using the Teach-Back Method.

Day 2 (Wednesday): Patients recall previous session topics; unclear points are clarified. Education focuses on fluid and dietary restrictions and the importance of adherence, using the Teach-Back Method.

Day 3 (Friday): Patients summarize previous content; the researcher reinforces unclear areas. Education covers medication adherence and lifestyle habits, again using the Teach-Back Method.

Primary outcomes

  1. Depression scores

    Time frame: For 12 weeks The intervention group consisted of patients who received hemodialysis treatment on Tuesdays, Thursdays, and Saturdays, and the control group consisted of patients who received treatment on Mondays, Wednesdays, and Fridays.

    Individual education given to adult ESRD patients receiving hemodialysis using the TeachBack Method reduces depression levels.

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi

Other

Registry information

Official study title

The Effect of Individualised Education Using the Teach Back Method on Depression Levels in Hemodialysis Patients

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 17, 2025
Registry last updated
Jul 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.